Main Menu

Conduct and Structural Merger Remedies in Recent Healthcare Provider Deals

Katherine Jones and Lindsay Heyer
ABA Antitrust Healthcare Chronicle
February 2022

Consolidation in the healthcare industry continues to be a focus of regulatory agencies. The Federal Trade Commission and state Attorneys General have the main responsibility for scrutinizing proposed healthcare provider mergers and then challenging potentially anticompetitive transactions. As an alternative to a legal challenge, the agencies may agree to “remedies” that allow transactions to proceed subject to stipulations. There are two main types of remedies—conduct and structural.

In “Conduct and Structural Merger Remedies in Recent Healthcare Provider Deals,” published in ABA Antitrust Healthcare Chronicle, Senior Consultant Kate Jones and co-author Lindsay Heyer explore case studies of recent hospital transactions. They discuss how the two remedy strategies have been applied and where state approaches have differed from federal enforcement actions. They conclude that while conduct remedies require ongoing monitoring to assess their efficacy, they are often a tool employed by state enforcers, while the FTC continues to prefer structural remedies instead.

The article is available here (subscription necessary).

Jump to Page

We use cookies to optimize the performance of this site and give you the best user experience. By clicking "Accept," you agree to our use of cookies.

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.